Medicine Sanofi charged with manslaughter over birth defects linked to epilepsy drugBlau Medical News
Updated 7 hours ago ·
Published on 3 Aug 2020 6:29PM ·
FRENCH prosecutors have indicted pharma giant Sanofi for manslaughter over birth defects linked to an epilepsy drug, the company said today, in a long-running case that has also seen it charged with fraud.
The charges relate to the drug valproate, marketed as Depakine among other trade names, which studies say has caused disabilities in about 15,000-30,000 children whose mothers took the medicine while pregnant.
Effective July 2018, access to full reports will only be available with a subscription. Sign-up now and enjoy one (1) week free access!
Sign up or sign in here to comment.